3rd Annual Atlanta Precision Oncology Symposium

 

3rd Annual Atlanta Precision Oncology Symposium
E

2021 Expert Discussion on Advanced NSCLC: Is Osimertinib a Good Sequencing Choice for EGFRm Patients? When to Discontinue TKI Therapy? How to Approach Patients on Maintenance?

By 3rd Annual Atlanta Precision Oncology Symposium FEATURING Edward Garon, Nasser Hanna, Hossein Borghaei, Jesse Kirkpatrick
By 3rd Annual Atlanta Precision Oncology Symposium FEATURING Edward Garon, Nasser Hanna, Hossein Borghaei, Jesse Kirkpatrick
390 views
February 14, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

06:40
Lilly Medical Affairs

Communicating the Risk of Recurrence for Patients With HR+, HER2- Ea…

Feat. J. O’Shaughnessy

Featured Video

03:57
Lilly Medical Affairs

Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- …

Feat. K. Jhaveri
Videos
12:36

Genotype-Directed Therapy for Advanced NSCLC: Overview of Targeted T…

3rd Annual Atlanta Precision Oncology Symposium

H. Borghaei

539 views
26:48

Targeted Therapies for Advanced Urothelial Cancer: Erdafitinib for P…

3rd Annual Atlanta Precision Oncology Symposium

D. Petrylak

146 views
13:52

Targeted Therapy for Advanced NSCLC: Efficacy Analysis of RET, KRAS,…

3rd Annual Atlanta Precision Oncology Symposium

H. Borghaei

35 views
25:48

2021 Expert Discussion on GU Cancers: Should We Use Olaparib Before …

3rd Annual Atlanta Precision Oncology Symposium

E. Antonarakis, D. Petrylak, T. Zhang

233 views
26:48

Treatment of DNA Repair-Deficient Advanced Prostate Cancer

3rd Annual Atlanta Precision Oncology Symposium

E. Antonarakis

241 views
26:42

2021 Expert Discussion on Advanced NSCLC: Is Osimertinib a Good Sequ…

3rd Annual Atlanta Precision Oncology Symposium

E. Garon, N. Hanna, H. Borghaei, J. Kirkpatrick

390 views
23:13

Early Detection of Lung Cancer: Molecular Enrichment Strategy

3rd Annual Atlanta Precision Oncology Symposium

J. Kirkpatrick

95 views
18:36

Selecting Systemic First-Line Treatment in Stage IV NSCLC Without Dr…

3rd Annual Atlanta Precision Oncology Symposium

N. Hanna

324 views
20:20

2021 Expert Discussion on BC: How to Preoperatively Manage TNBC? How…

3rd Annual Atlanta Precision Oncology Symposium

I. Mayer, J. Litton, R. O’Regan

31 views
32:45

2021 Updates on Systemic Therapy for TNBC: Why Should We Choose Neoa…

3rd Annual Atlanta Precision Oncology Symposium

R. O’Regan

40 views
06:49

IO for mTNBC: Overview of the Efficacy Data

3rd Annual Atlanta Precision Oncology Symposium

J. Litton

345 views
13:30

ADCs & Targeted Therapies for Advanced TNBC: Can Sacituzumab Govitec…

3rd Annual Atlanta Precision Oncology Symposium

J. Litton

96 views
09:52

EGFR+ Advanced NSCLC: Should 1L Therapy Include an EGFR Inhibitor Re…

3rd Annual Atlanta Precision Oncology Symposium

E. Garon

98 views
15:01

EGFR+ Advanced NSCLC: Efficacy Data of TKIs in Combination vs. Alone…

3rd Annual Atlanta Precision Oncology Symposium

E. Garon

141 views
05:55

Sequence Algorithm for HER2+ Breast Cancer: Does Neratinib + Cape Ha…

3rd Annual Atlanta Precision Oncology Symposium

I. Mayer

28 views
05:03

CNS Metastases in HER2+ MBC: PFS Data on the Addition of Tucatinib t…

3rd Annual Atlanta Precision Oncology Symposium

I. Mayer

599 views
17:47

HER2+ MBC Sequencing Algorithm: Surveying the Data for Antibody-Drug…

3rd Annual Atlanta Precision Oncology Symposium

I. Mayer

33 views
14:04
3rd Annual Atlanta Precision Oncology Symposium

[PRIVATE] Targeted Therapies for mRCC: Surveying Efficacy Data for I…

Feat. T. Zhang
17:05
3rd Annual Atlanta Precision Oncology Symposium

[PRIVATE] Targeted Therapies for mRCC: Assessing IMDC Risk Criteria …

Feat. T. Zhang
08:45

Targeting Genetic Mutations in mNSCLC: Clinical Data Overview of RET…

3rd Annual Atlanta Precision Oncology Symposium

H. Dilks

282 views